Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)

JOURNAL ARTICLE published 20 August 2013 in Journal of Clinical Oncology

Authors: Fabrice Barlesi | Arnaud Scherpereel | Achim Rittmeyer | Antonio Pazzola | Neus Ferrer Tur | Joo-Hang Kim | Myung-Ju Ahn | Joachim G.J.V. Aerts | Vera Gorbunova | Anders Vikström | Elaine K. Wong | Pablo Perez-Moreno | Lada Mitchell | Harry J.M. Groen